
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.5
5353 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
3,899 Listeners
8,501 Listeners
90,886 Listeners
1,874 Listeners
995 Listeners
6,285 Listeners
2,855 Listeners
1,017 Listeners
7,700 Listeners
1,011 Listeners
3,506 Listeners
1,379 Listeners
7,837 Listeners
9,188 Listeners
5,646 Listeners
86,615 Listeners
111,827 Listeners
25,112 Listeners
2,052 Listeners
241 Listeners
23,921 Listeners
10,141 Listeners
1,286 Listeners
5,431 Listeners
1,193 Listeners
5,650 Listeners
410 Listeners
12,213 Listeners
6,062 Listeners
59 Listeners
46 Listeners
95 Listeners
4 Listeners
81 Listeners